Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging

Rui Wang1, Songlin Yu, Jeffry R Alger

  • 1State Key Laboratory of Brain and Cognitive Science, Beijing MRI Center for Brain Research, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.

European Radiology
|February 22, 2014
PubMed
Abstract

Insights

Multi-delay pseudo-continuous arterial spin labeling (pCASL) enables simultaneous cerebral blood flow (CBF) and arterial transit time (ATT) measurements. This advanced technique shows improved correlation with CT perfusion in moyamoya disease patients, suggesting its potential as a prognostic biomarker.

Area of Science:

  • Neuroimaging
  • Radiology
  • Vascular Neurology

Background:

  • Moyamoya disease is a cerebrovascular disorder characterized by progressive stenosis of intracranial arteries.
  • Accurate assessment of cerebral blood flow (CBF) and arterial transit time (ATT) is crucial for diagnosis and management.
  • Existing perfusion imaging techniques have limitations in simultaneous CBF and ATT quantification.

Purpose of the Study:

  • To introduce a multi-delay pseudo-continuous arterial spin labeling (pCASL) protocol for simultaneous CBF and ATT measurement.
  • To evaluate the correlation between multi-delay pCASL and CT perfusion imaging in patients with moyamoya disease.
  • To assess the potential of multi-delay pCASL as a prognostic imaging biomarker.

Main Methods:

  • A 4 post-labeling delay (PLD) pCASL protocol was implemented in 17 moyamoya disease patients undergoing CT perfusion.
  • Arterial transit time (ATT) was estimated using the multi-delay pCASL data and incorporated into CBF calculations.
  • Voxel-wise and region-of-interest (ROI)-based analyses were performed to compare ASL and CT perfusion measures.

Main Results:

  • Significant associations were found between multi-delay pCASL and CT perfusion across subjective ratings, grey matter, white matter, and major vascular territories.
  • The multi-delay pCASL protocol demonstrated improved correlation for CBF compared to single delay (2s PLD) ASL.
  • These findings highlight the enhanced accuracy of multi-delay ASL in quantifying perfusion parameters.

Conclusions:

  • Multi-delay pCASL allows for simultaneous measurement of CBF and ATT.
  • A strong correlation exists between multi-delay ASL and CT perfusion in moyamoya disease.
  • Multi-delay ASL offers improved CBF quantification and holds promise as a prognostic imaging biomarker for moyamoya disease.